Dosing of glucocorticosteroids in nephrotic syndrome
Pharmacodynamic actions and molecular mechanisms of corticosteroids in patients with nephrotic syndrome (NS) are poorly understood. The role of immunosuppressive and of direct stabilizing effects on the podocyte cytoskeleton needs to be defined. Without precise knowledge of the pathogenesis, optimal...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
01 December 2011
|
| In: |
Pediatric nephrology
Year: 2011, Jahrgang: 26, Heft: 12, Pages: 2095-2098 |
| ISSN: | 1432-198X |
| DOI: | 10.1007/s00467-011-1993-8 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00467-011-1993-8
|
| Verfasserangaben: | Otto Mehls, Peter F. Hoyer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1814406131 | ||
| 003 | DE-627 | ||
| 005 | 20230710121953.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220816s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00467-011-1993-8 |2 doi | |
| 035 | |a (DE-627)1814406131 | ||
| 035 | |a (DE-599)KXP1814406131 | ||
| 035 | |a (OCoLC)1389793110 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mehls, Otto |e VerfasserIn |0 (DE-588)1111580413 |0 (DE-627)865658137 |0 (DE-576)476191424 |4 aut | |
| 245 | 1 | 0 | |a Dosing of glucocorticosteroids in nephrotic syndrome |c Otto Mehls, Peter F. Hoyer |
| 264 | 1 | |c 01 December 2011 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.08.2022 | ||
| 520 | |a Pharmacodynamic actions and molecular mechanisms of corticosteroids in patients with nephrotic syndrome (NS) are poorly understood. The role of immunosuppressive and of direct stabilizing effects on the podocyte cytoskeleton needs to be defined. Without precise knowledge of the pathogenesis, optimal dosing cannot be established. The finding of Saadeh et al. [1] that dosing of glucocorticoids per body surface area is superior to dosing per kilogram body weight (BW) in terms of reducing the recurrence rate of NS is interesting; however, an overriding effect of age cannot be ruled out. It is unlikely that all patients with an initial presentation of NS require the same amount of glucocorticoid treatment as patients with recurrent disease. In the future, it may be more important to establish individual treatment strategies than to adapt high doses of glucocorticoids according to anthropometric measurements. | ||
| 700 | 1 | |a Hoyer, Peter F. |e VerfasserIn |0 (DE-588)1052638244 |0 (DE-627)788901974 |0 (DE-576)40842060X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric nephrology |d Berlin : Springer, 1987 |g 26(2011), 12, Seite 2095-2098 |h Online-Ressource |w (DE-627)254638872 |w (DE-600)1463004-7 |w (DE-576)074531689 |x 1432-198X |7 nnas |a Dosing of glucocorticosteroids in nephrotic syndrome |
| 773 | 1 | 8 | |g volume:26 |g year:2011 |g number:12 |g pages:2095-2098 |g extent:4 |a Dosing of glucocorticosteroids in nephrotic syndrome |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00467-011-1993-8 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220816 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1111580413 |a Mehls, Otto |m 1111580413:Mehls, Otto |d 910000 |d 910500 |e 910000PM1111580413 |e 910500PM1111580413 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1814406131 |e 417967940X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"4 S."}],"recId":"1814406131","origin":[{"dateIssuedDisp":"01 December 2011","dateIssuedKey":"2011"}],"person":[{"family":"Mehls","role":"aut","given":"Otto","display":"Mehls, Otto"},{"display":"Hoyer, Peter F.","given":"Peter F.","role":"aut","family":"Hoyer"}],"relHost":[{"note":["Gesehen am 06.12.05"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"title":[{"title_sort":"Pediatric nephrology","title":"Pediatric nephrology","subtitle":"journal of the International Pediatric Nephrology Association"}],"part":{"volume":"26","year":"2011","issue":"12","extent":"4","text":"26(2011), 12, Seite 2095-2098","pages":"2095-2098"},"id":{"issn":["1432-198X"],"eki":["254638872"],"zdb":["1463004-7"]},"pubHistory":["1.1987 -"],"origin":[{"publisher":"Springer ; Springer","dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}],"disp":"Dosing of glucocorticosteroids in nephrotic syndromePediatric nephrology","physDesc":[{"extent":"Online-Ressource"}],"recId":"254638872"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.08.2022"],"title":[{"title":"Dosing of glucocorticosteroids in nephrotic syndrome","title_sort":"Dosing of glucocorticosteroids in nephrotic syndrome"}],"name":{"displayForm":["Otto Mehls, Peter F. Hoyer"]},"id":{"doi":["10.1007/s00467-011-1993-8"],"eki":["1814406131"]}} | ||
| SRT | |a MEHLSOTTOHDOSINGOFGL0120 | ||